Starting with aspartic acid β esters undergoing acylation to differentiate the first substituent, linked to carbon-2, followed by Dakin-West conversion to keto-amide to introduce the second substituent, and ending with the Robinson-Gabriel cyclodehydration at 90°C for 30 minutes with either phosphorus oxychloride in DMF or catalytic sulfuric acid in acetic anhydride.
None of the in vivo or in vitro studies performed with toxic-oil-specific components, such as fatty acid anilides and esters of PAP, have provided evidence that these markers are causally involved in the pathogenesis of TOS.